Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1988 May;43(5):354–359. doi: 10.1136/thx.43.5.354

Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes.

M L Wilsher 1, D A Hughes 1, P L Haslam 1
PMCID: PMC461245  PMID: 3194863

Abstract

Human pulmonary surfactant has not been shown to have immunoregulatory properties. A study was designed to examine the effect of whole surfactant (lyophilised bronchoalveolar lavage fluid) and purified surfactant lipids obtained from normal lungs of three species (man, pig, rabbit) on the lymphoproliferative responses of human peripheral blood lymphocytes to mitogens and alloantigens. Whole surfactant and purified surfactant lipids suppressed the proliferative response to phytohaemagglutinin in a dose dependent manner. The purified lipid fraction appeared to cause more suppression than whole surfactant in all the species. There was significant suppression of the proliferative response to B cell mitogens, T cell mitogens (pokeweed mitogen and phytohaemagglutinin), and alloantigens as tested by allogeneic mixed lymphocyte cultures. These results suggest an immunoregulatory role for pulmonary surfactant, most likely due to the lipid fraction.

Full text

PDF
354

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansfield M. J., Benson B. J. Identification of the immunosuppressive components of canine pulmonary surface active material. J Immunol. 1980 Sep;125(3):1093–1098. [PubMed] [Google Scholar]
  2. Ansfield M. J., Kaltreider H. B., Benson B. J., Caldwell J. L. Immunosuppressive activity of canine pulmonary surface active material. J Immunol. 1979 Mar;122(3):1062–1066. [PubMed] [Google Scholar]
  3. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  4. Curtiss L. K., Edgington T. S. Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation. J Immunol. 1977 Jun;118(6):1966–1970. [PubMed] [Google Scholar]
  5. Curtiss L. K., Edgington T. S. Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol. 1976 May;116(5):1452–1458. [PubMed] [Google Scholar]
  6. Dhillon D. P., Haslam P. L., Townsend P. J., Primett Z., Collins J. V., Turner-Warwick M. Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery. Eur J Respir Dis. 1986 May;68(5):342–350. [PubMed] [Google Scholar]
  7. Ettensohn D. B., Roberts N. J., Jr Human alveolar macrophage support of lymphocyte responses to mitogens and antigens. Analysis and comparison with autologous peripheral-blood-derived monocytes and macrophages. Am Rev Respir Dis. 1983 Sep;128(3):516–522. doi: 10.1164/arrd.1983.128.3.516. [DOI] [PubMed] [Google Scholar]
  8. Fujii D. K., Edgington T. S. Direct suppression of lymphocyte induction by the immunoregulatory human serum low density lipoprotein, LDL-In. J Immunol. 1980 Jan;124(1):156–160. [PubMed] [Google Scholar]
  9. Gilfillan A. M., Chu A. J., Smart D. A., Rooney S. A. Single plate separation of lung phospholipids including disaturated phosphatidylcholine. J Lipid Res. 1983 Dec;24(12):1651–1656. [PubMed] [Google Scholar]
  10. Haslam P., Lukoszek A., Longbottom J. L., Turner-Warwick M. Lymphocyte sensitization to Aspergillus fumigatus antigens in pulmonary diseases in man. Clin Allergy. 1976 May;6(3):277–291. doi: 10.1111/j.1365-2222.1976.tb01908.x. [DOI] [PubMed] [Google Scholar]
  11. Holt P. G. Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages. Clin Exp Immunol. 1986 Feb;63(2):261–270. [PMC free article] [PubMed] [Google Scholar]
  12. Morley C. J., Banhham A. D., Johnson P., Thorburn G. D., Jenkin G. Physical and physiological properties of dry lung surfactant. Nature. 1978 Jan 12;271(5641):162–163. doi: 10.1038/271162a0. [DOI] [PubMed] [Google Scholar]
  13. Morse J. H., Witte L. D., Goodman D. S. Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins. J Exp Med. 1977 Dec 1;146(6):1791–1803. doi: 10.1084/jem.146.6.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rivnay B., Globerson A., Shinitzky M. Peturbation of lymphocyte response to concanavalin A by exogenous cholesterol and lecithin. Eur J Immunol. 1978 Mar;8(3):185–189. doi: 10.1002/eji.1830080309. [DOI] [PubMed] [Google Scholar]
  15. Robinson P. C., Voelker D. R., Mason R. J. Isolation and culture of human alveolar type II epithelial cells. Characterization of their phospholipid secretion. Am Rev Respir Dis. 1984 Dec;130(6):1156–1160. doi: 10.1164/arrd.1984.130.6.1156. [DOI] [PubMed] [Google Scholar]
  16. Toews G. B., Vial W. C., Dunn M. M., Guzzetta P., Nunez G., Stastny P., Lipscomb M. F. The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol. 1984 Jan;132(1):181–186. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES